Drug Target Insights
 | |
| Discipline | Pharmacology |
|---|---|
| Language | English |
| Edited by | Giulio Zuanetti (interim) |
| Publication details | |
| History | 2006–Present |
| Publisher | |
| Yes | |
| Standard abbreviations | |
| ISO 4 | Drug Target Insights |
| Indexing | |
| ISSN | 1177-3928 |
| LCCN | 2007243676 |
| OCLC no. | 502638151 |
| Links | |
Drug Target Insights is a peer-reviewed open access academic journal focusing on drug treatment targets and clinical therapeutics. The journal was founded in 2006 by Monica Milani and is currently edited by Giulio Zuanetti. It was originally published by Libertas Academica, but SAGE Publications became the publisher in September 2016.[1] In 2020, the journal was transferred to AboutScience Srl.
Indexing
[edit]The journal is abstracted and indexed in the following bibliographic databases:[2]
According to Scopus, it has a 2020 CiteScore of 4.6, ranking 11th out of 67th in the category 'General Pharmacology, Toxicology and Pharmaceutics'.[3]
References
[edit]- ^ "Libertas Academica Journals to be published by SAGE". 19 September 2016. Archived from the original on 2017-02-02.
- ^ "Drug Target Insight". MIAR: Information Matrix for the Analysis of Journals. University of Barcelona. Retrieved 2021-11-07.
- ^ "Source Details: Drug Target Insights". Scopus. Retrieved 2021-11-07.
External links
[edit]
  | This article about a pharmacology journal is a stub. You can help Wikipedia by expanding it. See tips for writing articles about academic journals. Further suggestions might be found on the article's talk page. |